Analytical Data
-
Gene name
Carboxypeptidase B1
- Application
-
Alternative Names
CPB; PCPB; PASP; Pancreas-specific protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P15086
-
Expression Region
Ala111~Tyr417
-
Molecular Weight
39kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Carboxypeptidase B1 (CPB1) is a pancreatic enzyme that plays a crucial role in the digestion of proteins by hydrolyzing the C-terminal residues, primarily basic amino acids like lysine and arginine. This enzyme is involved in various physiological processes, including the activation of digestive proenzymes and the regulation of protein turnover. Recent studies have highlighted the potential therapeutic applications of CPB1 in conditions such as pancreatitis, obesity, and cancer, where protein metabolism is disrupted. The availability of recombinant CPB1 has been a significant advancement, allowing for more detailed studies of its structure-function relationship and potential applications in biotechnology and medicine. The expression and purification of recombinant CPB1 enable researchers to investigate its enzymatic activity, stability, and interactions with other molecules, paving the way for developing novel therapeutic strategies. Given its importance in health and disease, understanding the properties of CPB1 through recombinant techniques is essential for harnessing its potential in clinical and industrial applications.
